{"abstract":"The Food and Drug Administration (FDA) is announcing the renewal of the Anesthetic and Analgesic Drug Products Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the Anesthetic and Analgesic Drug Products Advisory Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect until the May 1, 2028, expiration date.","action":"Notice; renewal of Federal advisory committee.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2026/04/27/2026-08125.html","cfr_references":[],"citation":"91 FR 22539","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"Authority for the Anesthetic and Analgesic Drug Products Advisory Committee will expire on May 1, 2026, unless the Commissioner formally determines that renewal is in the public interest.","disposition_notes":null,"docket_ids":["Docket No. FDA-2022-N-0621"],"dockets":[],"document_number":"2026-08125","effective_on":null,"end_page":22542,"executive_order_notes":null,"executive_order_number":null,"explanation":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2026/04/27/2026-08125.xml","html_url":"https://www.federalregister.gov/documents/2026/04/27/2026-08125/advisory-committee-anesthetic-and-analgesic-drug-products-advisory-committee-renewal","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2026-08125?publication_date=2026-04-27","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2026-04-27/2026-08125/mods.xml","not_received_for_publication":null,"page_length":4,"page_views":{"count":22,"last_updated":"2026-04-25 08:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-04-27/pdf/2026-08125.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":null,"publication_date":"2026-04-27","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2026/04/27/2026-08125.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":22539,"subtype":null,"title":"Advisory Committee; Anesthetic and Analgesic Drug Products Advisory Committee; Renewal","toc_doc":"Anesthetic and Analgesic Drug Products Advisory Committee","toc_subject":"Charter Amendments, Establishments, Renewals and Terminations","topics":[],"type":"Notice","volume":91}